Epigenetic silencing of MORT is an early event in cancer and is associated with luminal, receptor positive breast tumor subtypes

Lukas Vrba, Bernard W Futscher

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Immortality is an essential characteristic of cancer cells; a recent transcriptomic study of epithelial cell immortalization has linked epigenetic silencing of the long noncoding RNA Mortal Obligate RNA Transcript (MORT; alias ZNF667-AS1) to this process. This study evaluated the epigenetic and transcriptional state of MORT in two premalignant conditions—ductal carcinomas in situ and colon adenomas. Results show that MORT silencing is an early epigenetic event in human carcinogenesis, likely occurring near the point where premalignant cells gain immortality; this epigenetic silencing is maintained throughout malignant transformation and metastatic growth. Additional associations between MORT loss and clinical and molecular features of breast tumors showed that silencing of MORT occurs predominantly in luminal, receptor-positive breast cancer; is associated with overexpression of CCND1 and mutations of GATA3; and is negatively correlated with TP53 mutations. Taken in toto, MORT silencing occurs early in breast carcinogenesis, probably during cellular immortalization, and precedes the development of invasive luminal breast cancer.

Original languageEnglish (US)
Pages (from-to)198-202
Number of pages5
JournalJournal of Breast Cancer
Volume20
Issue number2
DOIs
StatePublished - Jun 1 2017

Fingerprint

Epigenomics
Breast Neoplasms
Neoplasms
Carcinogenesis
Long Noncoding RNA
Mutation
Carcinoma in Situ
Adenoma
Colon
Breast
Epithelial Cells
RNA
Growth

Keywords

  • Breast neoplasms
  • Carcinogenesis
  • DNA methylation
  • Gene silencing
  • Long noncoding RNA

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

@article{304c47cd87fd43f9ab996f9b0e35f36c,
title = "Epigenetic silencing of MORT is an early event in cancer and is associated with luminal, receptor positive breast tumor subtypes",
abstract = "Immortality is an essential characteristic of cancer cells; a recent transcriptomic study of epithelial cell immortalization has linked epigenetic silencing of the long noncoding RNA Mortal Obligate RNA Transcript (MORT; alias ZNF667-AS1) to this process. This study evaluated the epigenetic and transcriptional state of MORT in two premalignant conditions—ductal carcinomas in situ and colon adenomas. Results show that MORT silencing is an early epigenetic event in human carcinogenesis, likely occurring near the point where premalignant cells gain immortality; this epigenetic silencing is maintained throughout malignant transformation and metastatic growth. Additional associations between MORT loss and clinical and molecular features of breast tumors showed that silencing of MORT occurs predominantly in luminal, receptor-positive breast cancer; is associated with overexpression of CCND1 and mutations of GATA3; and is negatively correlated with TP53 mutations. Taken in toto, MORT silencing occurs early in breast carcinogenesis, probably during cellular immortalization, and precedes the development of invasive luminal breast cancer.",
keywords = "Breast neoplasms, Carcinogenesis, DNA methylation, Gene silencing, Long noncoding RNA",
author = "Lukas Vrba and Futscher, {Bernard W}",
year = "2017",
month = "6",
day = "1",
doi = "10.4048/jbc.2017.20.2.198",
language = "English (US)",
volume = "20",
pages = "198--202",
journal = "Journal of Breast Cancer",
issn = "1738-6756",
publisher = "Korean Breast Cancer Society",
number = "2",

}

TY - JOUR

T1 - Epigenetic silencing of MORT is an early event in cancer and is associated with luminal, receptor positive breast tumor subtypes

AU - Vrba, Lukas

AU - Futscher, Bernard W

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Immortality is an essential characteristic of cancer cells; a recent transcriptomic study of epithelial cell immortalization has linked epigenetic silencing of the long noncoding RNA Mortal Obligate RNA Transcript (MORT; alias ZNF667-AS1) to this process. This study evaluated the epigenetic and transcriptional state of MORT in two premalignant conditions—ductal carcinomas in situ and colon adenomas. Results show that MORT silencing is an early epigenetic event in human carcinogenesis, likely occurring near the point where premalignant cells gain immortality; this epigenetic silencing is maintained throughout malignant transformation and metastatic growth. Additional associations between MORT loss and clinical and molecular features of breast tumors showed that silencing of MORT occurs predominantly in luminal, receptor-positive breast cancer; is associated with overexpression of CCND1 and mutations of GATA3; and is negatively correlated with TP53 mutations. Taken in toto, MORT silencing occurs early in breast carcinogenesis, probably during cellular immortalization, and precedes the development of invasive luminal breast cancer.

AB - Immortality is an essential characteristic of cancer cells; a recent transcriptomic study of epithelial cell immortalization has linked epigenetic silencing of the long noncoding RNA Mortal Obligate RNA Transcript (MORT; alias ZNF667-AS1) to this process. This study evaluated the epigenetic and transcriptional state of MORT in two premalignant conditions—ductal carcinomas in situ and colon adenomas. Results show that MORT silencing is an early epigenetic event in human carcinogenesis, likely occurring near the point where premalignant cells gain immortality; this epigenetic silencing is maintained throughout malignant transformation and metastatic growth. Additional associations between MORT loss and clinical and molecular features of breast tumors showed that silencing of MORT occurs predominantly in luminal, receptor-positive breast cancer; is associated with overexpression of CCND1 and mutations of GATA3; and is negatively correlated with TP53 mutations. Taken in toto, MORT silencing occurs early in breast carcinogenesis, probably during cellular immortalization, and precedes the development of invasive luminal breast cancer.

KW - Breast neoplasms

KW - Carcinogenesis

KW - DNA methylation

KW - Gene silencing

KW - Long noncoding RNA

UR - http://www.scopus.com/inward/record.url?scp=85021985082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021985082&partnerID=8YFLogxK

U2 - 10.4048/jbc.2017.20.2.198

DO - 10.4048/jbc.2017.20.2.198

M3 - Article

AN - SCOPUS:85021985082

VL - 20

SP - 198

EP - 202

JO - Journal of Breast Cancer

JF - Journal of Breast Cancer

SN - 1738-6756

IS - 2

ER -